Connect with us

Health

FDA advisers unanimously approve Alzheimer's drug

FDA advisers unanimously approve Alzheimer's drug

 


An FDA advisory committee on Monday unanimously endorsed the investigational drug donanemab as a treatment for early-stage Alzheimer's disease.

In an 11-0 vote, the Peripheral and Central Nervous System Drugs Advisory Committee stated that the benefits of donanemab outweigh the risks for the population of Alzheimer's patients with mild cognitive impairment and mild dementia who participated in donanemab's clinical trials.

The committee also voted 11-0 that available data show that donanemab is effective in treating this group of patients with Alzheimer's disease. I expressed my concerns last week. Although Alzheimer's patients with no or very low tau were excluded from the pivotal trials of donanemab, the committee overall agreed that the drug should not be restricted to Alzheimer's patients with a particular tau burden.

“The population-based evidence in this trial is very strong and consistent across subgroups,” said committee member Dean Folman, PhD, a biostatistician at NIH.

“The biomarker data also supported efficacy,” added committee member Kathleen Poston, M.D., of Stanford University in California. “The benefits outweigh the risks, as long as the risks are monitored.”

But during the meeting, Poston and his colleagues expressed concern about the lack of data on donanemab and other anti-amyloid drugs in African-American and Hispanic people. “Going forward, it's going to be important to have that data to make sure that these promising findings apply to the entire population of people with Alzheimer's,” Poston said.

FDA advisers suggested that while the risks of amyloid-related imaging abnormalities (ARIA) were evident in the trial data, many of them could be mitigated. Safeguards could be put in place to manage ARIA, and the risks “could be safely uncovered through the proposed MRI program and training,” noted Cynthia Carlson, MD, PhD, a member of the committee on medicine and public health at the University of Wisconsin-Madison.

Marwan Sabbagh, MD, a neurologist at Barrow Neurological Institute in Phoenix, who was not involved in the donanemab trial, summarized the views of most Alzheimer's patients who spoke at the conference hearing: “Patients with Alzheimer's have a 100% chance of worsening and losing their independence, compared to a 6% chance of having symptomatic ARIA,” Sabbagh said.

Donanemab was tested in a phase 3 clinical trial. Trailblazer ALZ2 The study included 1,736 patients with early-stage Alzheimer's disease. The drug met the study's primary endpoint of change from baseline in the Integrated Alzheimer's Disease Rating Scale (iADRS), slowing the decline compared to placebo (PThe drug also met its ranked secondary endpoint of less decline in Clinical Dementia Rating-Sum of Boxes (CDR-SB) at 76 weeks (P<0.001).

As with other anti-amyloid drugs, safety issues with donanemab have focused on ARIA with edema or exudate (ARIA-E) and ARIA with microhemorrhages and hemosiderin deposits (ARIA-H). Apoe 4 Homozygotes are at higher risk of infection than heterozygotes and non-carriers.

In TRAILBLAZER-ALZ 2, ARIA-E occurred in 24% of donanemab-treated participants and ARIA-H occurred in 31.4%. Two ARIA-related deaths were due to donanemab.

If approved, donanemab would be the third amyloid-targeting drug to reach the market. The first was the controversial aducanumab (Aduherm), which received accelerated approval. It was then abandoned, The second is Lecanemab (Leqembi); Fully FDA approved last year.

The FDA has not released a date for a final decision on donanemab. The FDA is not required to follow the advisory committee's recommendations but typically does.

  • Judy George He covers neurology and neuroscience news for MedPage Today and writes about brain aging, Alzheimer's, dementia, multiple sclerosis, rare diseases, epilepsy, autism, headaches, stroke, Parkinson's, amyotrophic lateral sclerosis, concussions, CTE, sleep, and pain. to follow

Sources

1/ https://Google.com/

2/ https://www.medpagetoday.com/neurology/alzheimersdisease/110575

The mention sources can contact us to remove/changing this article

What Are The Main Benefits Of Comparing Car Insurance Quotes Online

LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos

ExBUlletin

to request, modification Contact us at Here or [email protected]